Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1

NCT03007719 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Low Accrual

Conditions

Bladder Cancer

Interventions

DRUG: Fluorine F 18 Ara-G
PROCEDURE: Positron Emission Tomography
PROCEDURE: Magnetic Resonance Imaging

Sponsor

Lawrence Fong

Collaborators

[object Object]